Spire Healthcare Group Plc

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: GB00BNLPYF73
GBP
1.81
-0.42 (-18.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROCE of 9.35%

  • The company has been able to generate a Return on Capital Employed (avg) of 9.35% signifying low profitability per unit of total capital (equity and debt)
2

Low ability to service debt as the company has a high Debt to EBITDA ratio of 1.87 times

3

The company has declared Positive results for the last 4 consecutive quarters

4

With ROE of 4.14%, it has a very expensive valuation with a 1.34 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

GBP 748 Million (Small Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

124.21%

stock-summary
Debt Equity

0.63

stock-summary
Return on Equity

4.14%

stock-summary
Price to Book

1.02

Revenue and Profits:
Net Sales:
207 Million
(Quarterly Results - Jun 2014)
Net Profit:
-15 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.33%
0%
-14.33%
6 Months
-10.07%
0%
-10.07%
1 Year
-18.19%
0%
-18.19%
2 Years
-19.47%
0%
-19.47%
3 Years
-22.89%
0%
-22.89%
4 Years
-24.97%
0%
-24.97%
5 Years
31.3%
0%
31.3%

Spire Healthcare Group Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
11.64%
EBIT Growth (5y)
18.86%
EBIT to Interest (avg)
1.13
Debt to EBITDA (avg)
1.87
Net Debt to Equity (avg)
0.57
Sales to Capital Employed (avg)
1.06
Tax Ratio
32.11%
Dividend Payout Ratio
36.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.35%
ROE (avg)
2.37%
Valuation key factors
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
1.34
EV to EBIT
10.01
EV to EBITDA
5.58
EV to Capital Employed
1.21
EV to Sales
0.94
PEG Ratio
NA
Dividend Yield
94.39%
ROCE (Latest)
12.08%
ROE (Latest)
4.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Spire Healthcare Group Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 11.20% vs 13.39% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -6.81% vs 240.24% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,511.20",
          "val2": "1,359.00",
          "chgp": "11.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "253.50",
          "val2": "230.10",
          "chgp": "10.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "99.90",
          "val2": "93.00",
          "chgp": "7.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10.00",
          "val2": "-1.40",
          "chgp": "-614.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "26.00",
          "val2": "27.90",
          "chgp": "-6.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "93.50%",
          "val2": "93.10%",
          "chgp": "0.04%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,511.20
1,359.00
11.20%
Operating Profit (PBDIT) excl Other Income
253.50
230.10
10.17%
Interest
99.90
93.00
7.42%
Exceptional Items
-10.00
-1.40
-614.29%
Consolidate Net Profit
26.00
27.90
-6.81%
Operating Profit Margin (Excl OI)
93.50%
93.10%
0.04%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 11.20% vs 13.39% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -6.81% vs 240.24% in Dec 2023

stock-summaryCompany CV
About Spire Healthcare Group Plc stock-summary
stock-summary
Spire Healthcare Group Plc
Hospital
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company operates approximately 39 hospitals and over 8 clinics across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services. The Company offers a range of primary care, consulting and diagnostic services. The Company's serves a patient mix consisting of private medical insurance (PMI), self-pay and National Health Service (NHS) patients. The Company's primary activities include diagnostics, such as imaging, magnetic resonance imaging or computerized tomography scanning and pathology; out-patient services, such as consulting, treatments, health checks and physiotherapy, and in-patient daycase procedures, such as orthopedics, cardiology, neurology, oncology and general surgery.
Company Coordinates stock-summary
Company Details
3 Dorset Rise , LONDON None : EC4Y 8EN
Registrar Details